38. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635–645. 39. Hooker CW, Hurlin PJ (2006) Of Myc and Mnt. J Cell Sci 119: 208–216. 40. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, et al. (2002) A stem cell molecular signature. Science 298: 601–604. 41. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, et al. (2005) LIF/ STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885–896. 42. Murphy MJ, Wilson A, Trumpp A (2005) More than just proliferation: Myc function in stem cells. Trends Cell Biol 15: 128–137. 43. Zhong JF, Zhao Y, Sutton S, Su A, Zhan Y, et al. (2005) Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells. Proc Natl Acad Sci U S A 102: 2448–2453. 44. Gandarillas A, Watt FM (1997) c-Myc promotes differentiation of human epidermal stem cells. Genes Dev 11: 2869–2882. 45. Arnold I, Watt FM (2001) c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol 11: 558–568. 46. Habib T, Park H, Tsang M, de Alboran IM, Nicks A, et al. (2007) Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J Cell Biol 179: 717–731. 47. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, et al. (2004) c- Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18: 2747–2763. 48. Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Rose W, et al. (2008) Hematopoietic stem cell function and survival depend on c-Myc and N- Myc activity. Cell Stem Cell 3: 611–624. 49. Bechard M, Dalton S (2009) Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal. Mol Cell Biol 29: 2092–2104. 50. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676. 51. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318–324. 52. Meissner A, Wernig M, Jaenisch R (2007) Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 53. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2007) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 54. Wernig M, Meissner A, Cassady JP, Jaenisch R (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10–12. 55. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al. (2007) Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Wide- spread Tissue Contribution. Cell Stem Cell 1: 55–70. 56. Knoepfler PS, Zhang X-y, Cheng PF, Gafken PR, McMahon SB, et al. (2006) Myc influences global chromatin structure. EMBO Journal 25: 2723–2734. 57. Martinato F, Cesaroni M, Amati B, Guccione E (2008) Analysis of Myc-Induced Histone Modifications on Target Chromatin. PLoS ONE 3: e3650. 58. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, et al. (2006) Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet 2: e51. 59. Scacheri PC, Crawford GE, Davis S (2006) Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. Methods Enzymol 411: 270–282. 60. Lin C-H, Jackson AL, Guo J, Linsley PS, Eisenman RN (2009) Myc-regulated microRNAs attenuate embryonic stem cell differentiation.EMBO J in press. 61. Kleine-Kohlbrecher D, Adhikary S, Eilers M (2006) Mechanisms of transcrip- tional repression by Myc. Curr Topic Micro Immunol 302: 51–62. Myc Function in ES Cells 62. Goodliffe JM, Wieschaus E, Cole MD (2005) Polycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila. Genes Dev 19: 2941–2946. 63. Secombe J, Li L, Carlos L, Eisenman RN (2007) The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 21: 537–551. 64. Goodliffe JM, Cole MD, Wieschaus E (2007) Coordinated regulation of Myc trans-activation targets by Polycomb and the Trithorax group protein Ash1. BMC Mol Biol 8: 40. 65. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, et al. (2006) Myc- binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8: 764–770. 66. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A (1993) A c-myc mutation causes lethality before 10.5 days of gestation in homozygous and reduced fertility in heterozygous female mice. Genes Dev 7: 671–682. 67. Dubois NC, Adolphe C, Ehninger A, Wang RA, Robertson EJ, et al. (2008) Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development 135: 2455–2465. 68. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861–872. 69. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917–1920. 70. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141–146. 71. Lawlor ER, Soucek L, Brown-Swigart L, Shchors K, Bialucha CU, et al. (2006) Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res 66: 4591–4601. 72. Chen X, Xu H, Yuan P, Fang F, Huss M, et al. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106–1117. 73. Kim J, Chu J, Shen X, Wang J, Orkin SH (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049–1061. 74. Kidder BL, Yang J, Palmer S (2008) Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS One 3: e3932. 75. Cotterman R, Knoepfler PS (2009) N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS One 4: e5799. 76. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, et al. (2008) Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2: 333–344. 77. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, et al. (2003) MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4: 575–580. 78. Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, et al. (2007) Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128: 505–518. 79. Cole MD, Nikiforov MA (2006) Transcriptional activation by the Myc oncoprotein. Curr Top Micro Immunol 302: 33–50. 80. Shilatifard A (2006) Chromatin modifications by methylation and ubiquitina- tion: implications in the regulation of gene expression. Annu Rev Biochem 75: 243–269. 81. Mao DY, Watson JD, Yan PS, Barsyte-Lovejoy D, Khosravi F, et al. (2003) Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr Biol 13: 882–886. 82. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129–2141. PLoS ONE | www.plosone.org 13 November 2009 | Volume 4 | Issue 11 | e7839